Minerva Biotechnologies

Minerva Biotechnologies is a biotechnology company focused on developing innovative therapies for cancer and advancing stem cell technologies. The company’s primary revenue streams come from licensing its proprietary technologies and forming strategic partnerships with pharmaceutical and biotech firms. Founded in 1999 and headquartered in Waltham, Massachusetts, Minerva is notable for its work on the MUC1* cancer target and for pioneering methods to generate clinical-grade human stem cells without animal products. Candidates should be aware that Minerva’s research-driven culture emphasizes translational science and collaboration with academic and industry leaders. The company’s mission centers on creating transformative treatments that address unmet medical needs in oncology and regenerative medicine.

Recent Posts by Minerva Biotechnologies

1-6 of 6